To determine whether PRL1 plays a role in the invasiveness and progression of GBM, we analyzed PRL1 protein levels in 10 NBTs and 26 grade IV GBM samples using Western blot, and detected markedly high levels in the tumors in a subset of NBT/GBM tissues (Figure 1B). The gene discussed is PTP4A1; the disease is glioblastoma.